{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/25668130",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/2093400876"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#25668130",
  "code": "KB63.4",
  "source": "http://id.who.int/icd/entity/25668130",
  "classKind": "category",
  "title": {
    "@language": "en",
    "@value": "Transitory tyrosinaemia of newborn"
  },
  "definition": {
    "@language": "en",
    "@value": "Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Transitory tyrosinaemia of newborn"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "neonatal tyrosinemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "transient neonatal hypertyrosinemia"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "transitory neonatal tyrosinemia"
      }
    }
  ]
}